Supreme Court lets mifepristone be mailed, sold
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Supreme Court temporarily blocks the appeals court's restrictions, allowing mifepristone to be obtained by mail, pharmacies, and telehealth for at least one week.
- Justice Samuel Alito signed the order on Monday, giving women a week‑long window before the Court fully reviews the case.
- Louisiana sued to limit the pill, arguing its availability undermines the state's abortion ban.
- Students for Life president Kristan Hawkins condemned the decision, calling providers "pill traffickers" and big pharma.
- Dr. Angel Foster of the Massachusetts Abortion Access Project said her group was ready to switch to misoprostol‑only but reverted after the order, pledging continued nationwide care.
Why it matters: Women seeking abortions gain a week of continued access to mifepristone via mail and pharmacies, while anti‑abortion groups lose a legal foothold; the week‑long reprieve may sustain demand for medication abortions and pressure state bans.
Ask SkimNews
